Our data clearly suggest that the class I Arf-mediated control of the Golgi exit and subsequent supply of secretion products to the plasma membrane is a key event in the maintenance of hypersecretion in neuroendocrine cancer cells. This evidence concerns the gene CDKN2A and neuroendocrine carcinoma.